Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Nov 6;4(11):e293.
doi: 10.1371/journal.pmed.0040293.

New approaches to filling the gap in tuberculosis drug discovery

Martina Casenghi  1 , Stewart T Cole, Carl F Nathan
Affiliations

New approaches to filling the gap in tuberculosis drug discovery

Martina Casenghi et al. PLoS Med. .

Abstract

For the first time in decades, say the authors, there is a tuberculosis drug pipeline, but the paucity of candidates is still cause for alarm.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Global TB Drug Pipeline, January 2007 (Figure: Kindly provided by STOP TB Partnership Working Group on New TB Drugs)
BTTTRI, Beijing Tuberculosis and Thoracic Tumor Research Institute; CDC, Centers for Disease Control and Prevention; DMID, Division of Microbiology and Infectious Diseases; ITR, Institute for Tuberculosis Research; KRICT, Korean Research Institute of Chemical Technology; NERC, Natural Environment Research Council; NIAID, National Institute of Allergy and Infectious Disease; NIH, National Institutes of Health; TAACF, Tuberculosis Antimicrobial Acquisition and Coordinating Facility; TBRU, Tuberculosis Research Unit; TBTC, Tuberculosis Trials Consortium; TDR, Special Programme for Research and Training in Tropical Diseases; WHO, World Health Organization
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Nwaka S, Ridley RG. Virtual drug discovery and development for neglected diseases through public-private partnerships. Nat Rev Drug Discov. 2003;2:919–928. - PubMed
    1. Nwaka S, Hudson A. Innovative lead discovery strategies for tropical diseases. Nat Rev Drug Discov. 2006;5:941–955. - PubMed
    1. Chirac P, Torreele E. Global framework on essential health R&D. Lancet. 2006;367:1560–1561. - PubMed
    1. Nathan C. Antibiotics at the crossroads. Nature. 2004;431:899–902. - PubMed
    1. Alekshun MN, Levy SB. Molecular mechanisms of antibacterial multidrug resistance. Cell. 2007;128:1037–1050. - PubMed

MeSH terms

Substances